Risk assessment of new psychoactive substances - EMCDDA - Europa

More documents

Recommendations

Info

Risk assessment of new psychoactive substances: operating guidelinesSummary of the technical reportSummary of a maximum of 800 words, to be provided by the EMCDDA.64
Domain B: Dependence and abuse potentialB1. Animal in vivo and in vitro dataRL: 0 1 2 3 4 nExpert’s comments:B2. Human dataRL: 0 1 2 3 4 nExpert’s comments:65
Page 5:
ContentsAcknowledgements 5Foreword
Page 13 and 14:
IntroductionThese guidelines are a
Page 17 and 18: Chapter 1Legal basis and scope1.1 L
Page 19 and 20: factors that would warrant such act
Page 23 and 24: Chapter 2General considerations for
Page 25 and 26: 2.6 Quality of dataIn the final eva
Page 29 and 30: Chapter 3A conceptual framework for
Page 31 and 32: (family, neighbourhood and communit
Page 35 and 36: Chapter 4Headings for the Risk Asse
Page 37 and 38: Descriptive elements• Name of the
Page 39 and 40: (c) Social risksSome public health
Page 41 and 42: • Evidence that the same groups o
Page 43: Elements for examining the conseque
Page 47: Chapter 6ConclusionThe Risk Assessm
Page 51 and 52: Annex ITechnical reportThe EMCDDA i
Page 53 and 54: D1.1.D1.2.Animal dataHere, data reg
Page 55 and 56: E6. Possible appeal of the new psyc
Page 59 and 60: Annex IISemi-quantitative assessmen
Page 61 and 62: 8 subgroups. All members give numer
Page 63: Step 4Delphi approach:On the day of
Page 68 and 69: Risk assessment of new psychoactive
Page 74: Risk assessment of new psychoactive
Page 90 and 91: European Monitoring Centre for Drug
Page 92: About the EMCDDAThe European Monito
show all

Risk assessment of new psychoactive substances - EMCDDA - Europa

Create successful ePaper yourself

Delete template?

Save as template?